logo
  

Toyota, Suzuki To Start Production Of New SUV Model For Sale In India

Japanese automakers Toyota Motor Corp. (TYT.L,TM) and Suzuki Motor Corp. (SZKMF.PK), who are in business partnership, announced Friday that they will start production of a new SUV model developed by Suzuki at Toyota Kirloskar Motor Pvt. Ltd. or TKM from August.

Maruti Suzuki India Limited and TKM will market the new model in India as Suzuki and Toyota models, respectively. Furthermore, the two companies are planning to export the new model to markets outside India including Africa.

Toyota and Suzuki said they are promoting mutual supply of vehicles globally.

Both companies had signed a memorandum of understanding for a business alliance in 2017. Since then, Toyota's strength in electrification technologies and Suzuki's strength in technologies for compact vehicles have been used for joint collaboration in production.

In the Indian model of the new vehicles, the powertrains will be equipped with mild hybrid developed by Suzuki and strong hybrid developed by Toyota.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Health insurer Humana Inc. reported Wednesday a net loss for the fourth quarter that slightly widened from last year, hurt primarily by charges associated with productivity initiatives, despite 6.6 percent revenue growth. Adjusted earnings for the quarter topped analysts' expectations, while quarterly revenues missed it by a whisker. South Plainfield, New Jersey-based Two Rivers Coffee is recalling its peanut butter single serve hot chocolate pods citing an undeclared peanut allergen, the U.S. Food Drug Administration said. The recall involves peanut butter single serve hot chocolate pods distributed as "Brooklyn Bean Peanut Butter Cup Hot Cocoa", "Pingo Peanut Butter Cookie Hot Chocolate" and ... Shares of Novartis AG were losing around 2 percent in the early morning trading in Switzerland after the drug major reported Wednesday sharply lower profit in its fourth quarter with weak sales as well as the absence of prior year's hefty Roche income. Adjusted earnings, however, topped market estimates, while top line missed their view. Further, the company announced higher dividend...
Follow RTT